Indusatumab
Indusatumab (5F9 Monoclonal antibody) is a monoclonal antibody against human GUCY2C (Guanylate cyclase 2C). Indusatumab can be used to synthesize ADCs, such as Indusatumab vedotin. Indusatumab can be used in cancer research[1].
Product Specifications
CAS Number
1497400-26-6
Product Name Alternative
5F9 Monoclonal antibody
UNSPSC
12352203
Target
Guanylate Cyclase
Type
Inhibitory Antibodies
Related Pathways
GPCR/G Protein
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/indusatumab.html
Purity
99.0
Solubility
10 mM in DMSO
Smiles
[Indusatumab]
Molecular Weight
(145.206 kDa)
References & Citations
[1]e Goeij BE, et al. New developments for antibody-drug conjugate-based therapeutic approaches. Curr Opin Immunol. 2016 Jun;40:14-23.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1376577-01 0.02 mg (E-Coli)
Recombinant Human Putative cancer susceptibility gene HEPN1 protein (HEPN1)
Sign In for Pricing
View Details MBS1376577-02 0.1 mg (E-Coli)
Recombinant Human Putative cancer susceptibility gene HEPN1 protein (HEPN1)
Sign In for Pricing
View Details MBS1376577-03 0.02 mg (Yeast)
Recombinant Human Putative cancer susceptibility gene HEPN1 protein (HEPN1)
Sign In for Pricing
View Details MBS1376577-04 0.1 mg (Yeast)
Recombinant Human Putative cancer susceptibility gene HEPN1 protein (HEPN1)
Sign In for Pricing
View Details MBS1376577-05 0.02 mg (Baculovirus)
Recombinant Human Putative cancer susceptibility gene HEPN1 protein (HEPN1)
Sign In for Pricing
View Details